38,087 Shares in Merck KGaA $MKGAF Acquired by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAFFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 38,087 shares of the company’s stock, valued at approximately $4,894,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $942,087,000. Bank of Nova Scotia purchased a new position in shares of Merck KGaA during the second quarter worth approximately $281,696,000. Danske Bank A S acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $276,535,000. Korea Investment CORP acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $239,191,000. Finally, Great Lakes Advisors LLC acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $183,444,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.

Merck KGaA Stock Down 3.9%

MKGAF stock opened at $158.15 on Friday. The company has a market cap of $20.44 billion, a price-to-earnings ratio of 24.14 and a beta of 0.96. The company has a fifty day moving average price of $163.21 and a 200 day moving average price of $148.95. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56.

About Merck KGaA

(Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Recommended Stories

Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAFFree Report).

Institutional Ownership by Quarter for Merck KGaA (OTCMKTS:MKGAF)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.